01 July, 2017
The company's price to sales ratio for trailing twelve months is 0.70 and price to book ratio for most recent quarter is 0.00, whereas price to cash per share for the most recent quarter is 2.24. A total of 2.97 Million shares exchanged hands during the intra-day trade compared with its average trading volume of 819.86 Million shares, while its relative volume stands at 3.62. Keeping in view the above important information, Rennova Health Inc (NASDAQ:RNVA) stock price level can be now recognized as a major resistance and therefore the stock is an overall downtrend, as a stock's price remains below the 200 SMA on the daily time frame.
In order to check on the sell-side rational, we can also take a peek at some technical indicators.
Over the last 5 years, Rennova Health, Inc. has averaged a 48.20% YoY EPS growth rate and a 120.80% revenue growth rate. The shares price has positioned -75.95% down over the past quarter while it has directed -82.54% toward a falling position throughout past six months. This company shares are 126036.36% off its target price of $555 and the current market capitalization stands at $3.13M. The stock carved out a 52-week low down at $0.28. The stock now has Weekly Volatility of 21.59% and Monthly Volatility of 22.77%. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. Yearly performance of the stock shows a bearish trend of -97.95% while year-to-date (YTD) performance reflected -84.34% negative outlook.
While taking a glance at financials, we can look at a number of key indicators.
Talking about profitability of the company, the profit margin percentage is 0% while its operating margin for the trailing twelve month is at -643.18%. ROI is a performance measure used to evaluate the efficiency of an investment or to compare the efficiency of a number of different investments. The company's current price-earnings ratio amounts above the average P/E ratio of 50.54 times earnings. Its Price to Cash Flow ratio shows the value of 0, whereas, the industry and sector ratio of Price to Cash Flow ticked at 24.9 and 14.86 respectively. The company's 5 year Earnings per share growth and Capital Spending growth remains at 0 and 0. The stock has a beta value of -0.57.
RNVA's fiscal year ends Dec 31, 2016 and the most recent quarter started on Mar 31, 2017. Total debt to equity ratio of the company for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.